BackBeijing Tiantan Biological Products , Ltd. Overview

Beijing Tiantan Biological Products , Ltd. Goodwill

Beijing Tiantan Biological Products , Ltd.'s goodwill is $570M.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$572.15M
↑ 0.00% YoYΔ $0.00 vs prior year quarter

Peer trimmed avg / median

Loading

Beijing Tiantan Biological Products , Ltd. Goodwill History

Loading

Beijing Tiantan Biological Products , Ltd. vs. peers: Goodwill Comparison

Loading

Beijing Tiantan Biological Products , Ltd. Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Beijing Tiantan Biological Products , Ltd. (600161.SS) FAQ

Beijing Tiantan Biological Products , Ltd. (600161.SS) currently reports a goodwill of $570M as of September 2026. That compares with $570M in the prior-year period — up 0.0% year over year. Use the charts on this page to explore Beijing Tiantan Biological Products , Ltd.'s goodwill history and peer comparisons.

Beijing Tiantan Biological Products , Ltd.'s goodwill was unchanged from $570M to $570M — essentially flat versus a year earlier (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Beijing Tiantan Biological Products , Ltd. reported $570M in goodwill as of September 2026. That compares with $570M in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $570M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Beijing Tiantan Biological Products , Ltd., and consider following 600161.SS for alerts when major investors trade the stock.

Beijing Tiantan Biological Products , Ltd. is classified in the Healthcare sector. On goodwill, it currently shows $570M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 600161.SS with unrelated industries.